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Abstract: In a previous study, it was shown that the lipid fraction, which is occasion-
ally observed in red blood cell hemolysates, represents cholesterol (Ch) associated
with phospholipid firmly bound to haemoglobin (termed Hb-Ch). The current study
was conducted to investigate whether Hb-Ch could affect the primary anti-oxidant en-
zyme defence system in human erythrocytes. Sixty healthy volunteers were used for
the current study. Group 1 consisted of 28 subjects without or with a low level of
Hb-Ch. Group 2 comprised 32 subjects with a considerably higher level of Hb-Ch.
The activities of erythrocyte superoxide dismutase, catalase, glutathione peroxidase
and glutathione reductase, as well as the content of methaemoglobin (metHb) were
measured in both groups. The results indicated that the amount of Hb-Ch neither influ-
enced the activities of the erythrocyte anti-oxidant enzymes nor altered the level of
metHb. However, a higher amount of Hb-Ch changed the correlations in the part of the
anti-oxidant defence system relating to glutathione, suggesting increased peroxidative
pressure from plasma lipids. Group 2 also had significantly increased concentrations
of total plasma Ch and triglycerides. Together, these facts are strong indications that
the anti-oxidant defence system in human erythrocytes finely retunes its composition
according to plasma oxidative demands.
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INTRODUCTION
In normal aerobic cells, excessive production of reactive oxygen species
(ROS) creates a situation known as cellular oxidative stress. This undesirable con-
dition has been implicated in the aging of organisms and in various diseases, such
339
doi: 10.2298/JSC0704339N
* Corresponding author.
# Serbian Chemical Society member.
as cancer.1–4 A number of enzymes, termed anti-oxidant enzymes, form a defence
system which has the capacity to eliminate ROS. Such a defence system is
ubiquitously expressed in all cell types and organisms.
Due to both its structural and functional characteristics, the human erythrocyte
is destined to be under continuous oxidative stress.5 The main source of ROS in the
erythrocyte is the auto-oxidation of oxyhaemoglobin (Hb) to methaemoglobin
(metHb), whereby superoxide anions are generated.6,7 Superoxide anions are dis-
mutated by Cu-Zn superoxide dismutase (SOD) to form hydrogen peroxide (H2O2),
which is decomposed by catalase (CAT) or reduced by a reduced glutathione (GSH)-de-
pendent mechanism by way of glutathione peroxidase (GSH-Px). These enzymes,
together with glutathione reductase (GR), maintain a high reduced/oxidised gluta-
thione ratio in red blood cells. In addition, various dietary antioxidants constitute the
major defence against oxidative damage in the erythrocyte.8 Possessing an anti-oxi-
dant activity, heamoglobin per se may be of importance in providing protection
against oxidative damage to erythrocytes.9 In addition, the cell membrane appears to
protect intra-erythrocytic Hb against extracellular oxidative stress.10
For the first time, cholesterol (Ch) associated with phospholipid (PL) was re-
cently detected bound to Hb in normal human erythrocytes (termed Hb-Ch), with a
binding stoichiometry of about two molecules of both Ch and PL per one Hb mole-
cule in Hb-Ch.
11 In the report, it was shown that Hb-Ch (up to 35 % of the total Hb)
was formed in a healthy population as a consequence of a seasonally-related ele-
vated plasma level of Ch (due to changes in plasma lipoprotein metabolism).11
Generally, (phopho)lipids promote the oxidation of human haemoglobin and the
formation of ROS.12,13 Cholesterol, on the other hand, has a protective effect.14
The principal aim of this study was to evaluate the functional importance of this
new lipid modification of Hb on the anti-oxidant system, which normally protects eryth-
rocytes from the continuous production of ROS and, consequently, from cellular injury.
The relationship between the content of Hb-Ch and the activities of the antioxidant en-
zymes in human erythrocytes was examined. The activities of SOD, GSH-Px, CAT and
GR, as well as the content of metHb in erythrocytes were measured. In addition, the total
plasma cholesterol (T-Ch), high density lipoprotein cholesterol (HDL-Ch), low density
lipoprotein cholesterol (LDL-Ch) and triglycerides in healthy male volunteers with dif-
ferent levels of Hb-Ch were measured. The results demonstrate that the amount of
Hb-Ch neither influences the activities of erythrocyte anti-oxidant enzymes nor alters the
level of metHb. Only a higher amount of Hb-Ch changed the correlations in the part of
the anti-oxidant defence system relating to glutathione.
EXPERIMENTAL
All the chemicals used in this study were purchased from Sigma (USA) and Merck (Germany),
unless indicated otherwise.
Sixty volunteers, aged 21–44 years old, were recruited for this study. Most of them were students
and workers in local institutes and universities. Only samples with normal haematological indices
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were used throughout the experiments. The history of participants did not reveal diseases, medical
conditions or the taking of drugs which could influence the activities of the anti-oxidant enzymes. In-
formed consent was obtained from all the subjects prior to initialising the study. The study took place
in the spring of 2005. After an initial screening, the subjects were classified into two groups according
to their level of Hb-Ch in the hemolysate. Group 1 (control group) consisted of 28 subjects without or
with a low level of Hb-Ch (up to 6 % of the total Hb). Group 2 comprised 32 subjects with a higher
level of Hb-Ch (from 7 % up to 20 % of the total Hb). No significant difference in smoking habits, al-
cohol intake, physical activity or in age difference was observed between the two groups.
Blood samples were obtained by venapuncture following an overnight fast. Citrate was used as
an anticoagulant (3.8 %). The plasma and erythrocytes were separated from each other by centri-
fugation at 1500 x g for 10 min. The buffy coat was removed and the red blood cells were washed
three times with isotonic (0.9 %) saline. All measurements described below were carried out using
fresh plasma and erythrocyte lysates.
The T-Ch and triglyceride concentrations were determined based on enzymatic methods using
Reanal (Hungary) kits. HDL-Ch was measured in the supernatant following the precipitation of
ApoB-containing lipoproteins with dextran sulphate (Serva, Germany) and MgCl2. The LDL-Ch
was calculated using the Friedewald formula.
The total Hb contents of the erythrocyte suspensions and the hemolysates were measured as
cyanmethaemoglobin using the Drabkin method. The metHb content was calculated as the percent-
age of the total Hb from the absorption spectrum from 500 to 700 nm.15
Hb-Ch was determined as described by Nikoli} et al.11 Briefly, aliquots of the hemolysates,
from which the membranes had been carefully removed, were extracted according to Reed et al.16
Cholesterol was enzymatically determined in the lipid extracts. The results are expressed as a per-
centage of the total Hb.
Anti-oxidant enzyme activities were determined using a Shimadzu UV-160 spectrophotometer.
All enzyme measurements were carried out in duplicate and average data of the GSH-Px activities
were normalised using the haemoglobin content (5 g %). Erythrocytes (0.5 ml) were hemolysed by
adding 3 ml of ice-cold distilled water. Haemoglobin was removed from an aliquot of the hemo-
lysate by the Tsuchihashi method.17 The upper layer was used for the determination of the SOD ac-
tivity, according to the method described by McCord and Fridovich.18 One unit of activity is defined
as the amount of enzyme necessary to decrease the rate of cytochrome c reduction to 50 % of the
maximum at 25 °C and pH 7.8. CAT was determined according to Claiborne.19 One unit of CAT ac-
tivity is defined as the amount of enzyme which decomposes 1 mmol H2O2 per min at 25 °C and pH
7.0. The activity of selenium GSH-Px was determined using a modification of the assay described
by Paglia and Valentine.20 One unit of GSH-Px activity is defined as the amount required to oxidise
1 nmol NADPH per min at 25 °C and pH 7.0. The GR activity was determined using the method of
Glatzle et al.21 One unit of GR activity is defined as the oxidation of 1 nmol NADPH per min at 25
°C and pH 7.6.
The data are represented as mean ± standard deviation (SD). Differences among groups were
assessed by analysis of the variance (ANOVA) followed by Tukey's post-hoc comparison test. Sta-
tistical significance was established by protocols as described in Hinkle et al.22 and p values <0.05
were considered significant.
RESULTS AND DISCUSSION
The activities of the erythrocyte anti-oxidant enzymes are summarised in Ta-
ble I. There was no statistically significant increase in erythrocyte SOD, CAT,
GSH-Px or GR activity in subjects with a higher level of Hb-Ch (group 2) com-
pared to the control group (group 1). In addition, no difference in the level of
metHb between the two groups were detected (Table I).
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TABLE I. The biochemical parameters of erythrocytes from patients classified into groups 1 and 2.
The enzymatic activity of SOD, CAT, GSH-Px and GR were also measured
Parameter Group 1 (n = 28) Group 2 (n = 32)
Hb/g L-1 142 ± 5 141 ± 6
Hb-Ch/% 4.3 ± 0.7 11.6 ± 1.5*
metHb/% 1.15 ± 0.14 1.19 ± 0.16
SOD 1.08 ± 0.09 1.09 ± 0.09
CAT 7.43 ± 1.26 7.53 ± 1.34
GSH-Px 11.46 ± 1.59 11.41 ± 1.57
GR 6.37 ± 0.97 6.19 ± 0.89
The values are mean ± SD. The units of activity are described in the Experimental section. The n val-
ues in parenthesis indicate the number of samples. Statistical significance was analysed by ANOVA;
* p <0.001.
A coordinated action of the components comprising the anti-oxidant defence
system is necessary to limit ROS production and to preserve the redox state. There-
fore, changes in the activity of some anti-oxidant components should be accompa-
nied by correlative changes in one or more of the anti-oxidant defence enzymes.
This phenomenon has been observed in the erythrocytes of Down's syndrome pa-
tients.23 In erythrocytes, the anti-oxidant enzymes SOD, CAT and GSH-Px have
complementary activities in the anti-oxidant defence system. H2O2, the product of
the reaction catalysed by SOD, is also the substrate for CAT and GSH-Px.
It has been shown that this anti-oxidant system, at the level of coordinated expres-
sion, functions in the domain of positive correlation between SOD and CAT.24 On the
other hand, glutathione-dependent enzymes in the anti-oxidant system are separately
regulated, probably via the concentration of (reduced) glutathione and the redox status
of the cell.25 The hypothesis made in this study is that by performing correlation analy-
ses between the activities of the anti-oxidant component between study groups 1 and 2,
an indication of the presence of coordinated actions of the anti-oxidant enzymes could
be obtained. The results of such analyses are presented in Table II.
TABLE II. Correlation analysis of the activity of erythrocyte anti-oxidant defence enzymes between
group 1 (horizontal categories) and group 2 (vertical categories)
SOD CAT GSH-Px GR
SOD 0.636** 0.186 0.268
CAT –0.147 0.246 0.405
GSH-Px 0.108 0.539* –0.213
GR 0.198 0.241 0.525*
Three significant correlations were observed (indicated in bold text). Statistical significance was
analysed by ANOVA; *p < 0.01; **p < 0.001.
Several points and conclusions can be drawn. Apositive correlation between the
activities of CAT and SOD in group 1 was found, implying that H2O2 is a molecular
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species connecting this part of the anti-oxidant enzyme protection system in human
erythrocytes, both without or with a low level of Hb-Ch (Fig. 1). This result is in ac-
cordance with that obtained from a group of 220 healthy Danish individuals. The au-
thors reported that erythrocyte SOD activity was positively correlated with CAT but
there were no significant correlations between GSH-Px and any of the other enzymes
measured.26 In group 2 there was positive correlation between the activities of
GSH-Px and CAT, as well as between GR and GSH-Px. This reveals that lipid perox-
ides are the dominant chemical entity connecting this part of the anti-oxidant enzyme
system in erythrocytes with a higher level of Hb-Ch (Fig. 1).
The presented results lead to the conclusion that the presence of Hb-Ch does
not favour the oxidation of Hb to metHb and that the level of Hb-Ch should corre-
late with the level of plasma lipids (as a possible exogenous source of erythrocyte
peroxides). The content of plasma lipids in study groups 1 and 2 were determined
and are presented in Table III. Statistically higher concentrations of T-Ch and tri-
glycerides were found in group 2. It should be emphasised that all individual val-
ues for the plasma lipids were within the reference range (considering the age of
the participants).
The presented results lead to three significant conclusions. Firstly, the amount
of Hb-Ch has no direct influence on the production of superoxide radicals originat-
ing from the transformation of Hb to metHb. Secondly, a higher level of Hb-Ch
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Fig. 1. A schematic representation of a part of the anti-oxidant enzyme system in erythrocytes.
O2
–: superoxide radical; H2O: water; Cu-Zn SOD: copper-zinc superoxide dismutase; CAT:
catalase; H2O2: hydrogen peroxide; GSH-Px: glutathione peroxidase; GSH: reduced glutathione;
GSSG: oxidised glutathione; GR: glutathione reductase; NADPH+: reduced nicotinamide adenine
dinucleotide phosphate; NADP+: nicotinamide adenine dinucleotide phosphate; LOOH: lipid
hydroperoxide; LOH: lipid alcohol.
correlates with alterations in the relationship between the activities of erythrocyte
anti-oxidant enzymes, suggesting an increasing peroxidative pressure from the
plasma. Thirdly, individuals with a higher level of Hb-Ch (group 2) have increased
concentrations of T-Ch and triglycerides in their plasma. The last two points (when
considered together) further underline the necessity to control diets, particularly of
inhabitants in the western world where obesity and heart disease are on the in-
crease. Caloric restriction leading to reduced body weight, lower T-Ch and reduced
plasma lipid peroxidation is the preferred method to limit the above-described dis-
eases. As a consequence, both the level of Hb-Ch and the peroxidative pressure on
erythrocytes from the plasma would also decrease. Caloric restriction is, therefore,
the preferred choice, compared with the intake of large quantities of anti-oxidants,
such as vitamin E, to limit erythrocyte peroxidative pressure from plasma.27 Stud-
ies which will hopefully lead to the recognition of the mechanisms and factors that
govern the formation and accumulation of Hb-Ch in human erythrocytes are
currently being pursued.
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U prethodnom radu pokazano je da lipidna frakcija koja se javqa u hemolizatu
zdravih qudi predstavqa holesterol (asosovan sa fosfolipidima) ~vrsto vezan za he-
moglobin (Hb-Ch). U ovom radu ispitivan je uticaj Hb-Ch na anti-oksidativni enzimski
sistem u humanim eritrocitima. Odre|ena je aktivnost superoksid-dizmutaze, katala-
ze, glutation-peroksidaze i glutation-reduktaze, kao i sadr`aj met-hemoglobina (metHb)
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TABLE III. The biochemical parameters of plasma from patients classified into groups 1 and 2
Parameter Group 1 (n = 28) Group 2 (n = 32)
T-Ch 3.78 ± 0.73 4.46 ± 0.75*
LDL-Ch 2.43 ± 0.51 2.76 ± 0.70
HDL-Ch 1.01 ± 0.20 1.08 ± 0.14
Triglycerides 0.86 ± 0.30 1.35 ± 0.40**
The values are mean ± SD and the lipids are expressed in mmol/l. The values in parenthesis indicate
the number of samples. Statistical significance was analysed by ANOVA; * p <0.01; **p<0.001.
u eritrocitima 60 qudi, podeqenih u dve grupe na osnovu koli~ine Hb-Ch. Rezultati
pokazuju da koli~ina prisutnog Hb-Ch ne mewa aktivnost merenih enzima, niti nivo
metHb. Me|utim, u grupi ispitanika sa pove}anim sadr`ajem Hb-Ch zapa`ene su korela-
tivne promene u delu anti-oksidativnog enzimskog sistema povezanog sa glutationom.
U istoj grupi detektovane su i ve}e koncentracije ukupnog holesterola i triglicerida
u plazmi, {to zajedno ukazuje na pove}ani peroksidativni pritisak iz plazme. Ovi
rezultati ukazuju da odbrambeni anti-oksidativni enzimski sistem u humanim eritro-
citima prilago|ava svoju organizaciju prema zahtevima iz svog okru`ewa.
(Primqeno 29. novembra 2005)
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